Compounds > norfloxacin

norfloxacin and quercetin

norfloxacin has been researched along with quercetin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hossion, AM; Iwado, A; Kandahary, RK; Ogawa, W; Otsuka, N; Sasaki, K; Tsuchiya, T; Zamami, Y1
Hossion, AM; Iwado, A; Kandahary, RK; Ogawa, W; Sasaki, K; Tsuchiya, T; Zamami, Y1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

3 other study(ies) available for norfloxacin and quercetin

ArticleYear
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
    Bioorganic & medicinal chemistry letters, 2010, Sep-01, Volume: 20, Issue:17

    Topics: Anti-Bacterial Agents; Drug Design; Enterococcus; Glucosides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quercetin; Vancomycin

2010
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
    Journal of medicinal chemistry, 2011, Jun-09, Volume: 54, Issue:11

    Topics: Animals; Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Design; Enzyme Inhibitors; Galactosides; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Targeted Therapy; Quercetin; Rats; Rats, Wistar; Topoisomerase II Inhibitors

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013